Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes (TDE)
研究概览
详细说明
One thousand outpatients will be enrolled over two years at two university-affiliated primary care clinics. Patients will be assigned to one of three study arms: those who want genetic testing for diabetes risk will be randomly assigned to either receive the testing in addition to the SRA (SRA+G) or to receive the SRA only (SRA-only). Those who do not wish to have genetic testing will receive the SRA only. All patients will be surveyed at baseline, immediately after going through the SRA (risk-counseling visit; 2-4 weeks after initial visit), at 3 months post risk counseling visit and at 12 months post risk counseling visit. BMI, waist circumference, fasting plasma glucose and insulin will be measured at baseline and 12 months. Surveys will allow us to track patients' emotional responses to diabetes risk information and changing perceptions of personal risk for Type 2 diabetes over time, and to see if these correlate with subsequent diet and exercise behaviors.
We will use a linear model to assess the effects of genetic testing among the three study groups, using HOmeostasis Model Assessment of Insulin Resistance (HOMA-IR) and weight loss as the primary outcomes. We will use generalized linear ordinal regression models to fit the ordinal survey outcomes of risk perceptions to the continuous HOMA-IR and weight outcome variables.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
North Carolina
-
Durham、North Carolina、美国、27705
- Duke Family Medicine at Pickens
-
Durham、North Carolina、美国、27705
- Duke Health Center at Pickett Rd
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Are male or female outpatients
- No self-reported history of diabetes
- No self-reported history of prior genetic testing for diabetes
- Not pregnant (self report)
- Are ≥18 and <81 years of age
- Scheduled to receive serum glucose test in participating clinic
- Fasting at time of blood draw (no food or drink - except water - previous 8 hours: self report)
- Able and willing to give legally effective consent
- Able and willing to participate in patient questionnaires
- Ambulatory
Exclusion Criteria:
- Previously or currently taking medications for lowering glucose (i.e., exenatide, pramlintide, metformin, rosiglitazone, pioglitazone, or future diabetes drugs) based on self-report and/or prescreening
- Self-report of current or prior diabetes diagnosis
- Self-reported prior history of genetic testing for diabetes
- Baseline serum glucose test result >125
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:SRA+genetic test
patients randomized to receive genetic test for type 2 diabetes risk will be followed and surveyed and will be counseled based on SAR and genetic risk for type 2 diabetes
|
patients interested in genetic testing will be randomly assigned to either get testing for type 2 diabetes or not.
All arms with receive standardized risk asessements.
This study is evaluating behavior after receipt of genetic risk information and different types of counseling.
|
|
无干预:SRA only
Patients randomized to not get genetic testing will be followed and surveyed and will be counseled based on SRA only
|
|
|
无干预:no testing control
Patients not interested in genetic testing will be followed and surveyed.
Counseling will be based on SRA only
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Percentage of weight loss
大体时间:12 months
|
12 months
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Change in perceptions of personal risk for Type 2 diabetes
大体时间:12 months
|
12 months
|
|
Change in HOmeostasis Model Assessment of Insulin Resistance (HOMA-IR)
大体时间:12 months
|
12 months
|
合作者和调查者
合作者
调查人员
- 首席研究员:Geoffrey Ginsburg, Md, PhD、Institute for Genome Sciences and Policy, Duke University
- 首席研究员:Alex Cho, MD、Institute for Genome Sciences and Policy, Duke University
- 首席研究员:Scott Joy, MD、Duke University
- 首席研究员:Susanne Haga, PhD、Institute for Genome Sciences and Policy, Duke University
- 首席研究员:Isaac Lipkus, PhD、Institute for Genome Sciences and Policy, Duke University
- 首席研究员:Gloria Trujillo, MD、Duke University
- 首席研究员:Julianne O'Daniel, PhD、Institute for Genome Sciences and Policy, Duke University
出版物和有用的链接
一般刊物
- Waxler JL, O'Brien KE, Delahanty LM, Meigs JB, Florez JC, Park ER, Pober BR, Grant RW. Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders. J Genet Couns. 2012 Oct;21(5):684-91. doi: 10.1007/s10897-012-9486-x.
- Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS. Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Serv Res. 2012 Jan 18;12:16. doi: 10.1186/1472-6963-12-16.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.